Theme 11 Cognitive and psychological assessment and support

Acknowledgments:

JPND-NEEDSinALS, BMBF-PaCeMed, BMBF-MND-Net.

Acknowledgments:

WH was supported by the Beryl-Bayley Post-doctoral Research Fellowship, Motor Neurone Disease Research Institute of Australia

Acknowledgments:

This work was supported by Grants-in Aid from the Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan.

Acknowledgments:

The authors thank all patients for their participation in this study, and Mr. H Shimada and Mr. N Honma for SPECT data extraction and analysis. This study was supported in part by Grants-in-Aid for Scientific Research (C) 18K07491 (to M.I.) and 16K09665 (to Y.I.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.

Acknowledgments:

We thank all the patients who participated in this study.

Acknowledgments:

Supported by Muscular Dystrophy Association Care Center Grant, Atrium Health Foundation Carolinas ALS Funds as well as Pinstripes Foundation and ALS Charlotte Clinical Crew Funds.

Acknowledgments:

We would like to thank the Motor Neurone Disease Association (MNDA) for supporting the development of the cognitive screening pathway at the Sheffield MND Care Centre.

Acknowledgments:

This project is funded by a MND Research in Australia Mavis Gallienne and Graham Lang MND Victoria Research Grant.

Acknowledgments:

This study is funded by ALSA.

Acknowledgments:

This project is funded by the ALSA.

Acknowledgments:

Brazilian National Council for Scientific and Technological Development (401922/2014-6; 380754/2019-3). The authors declare no conflicts of interest.